ARIAD is a tiny biotech that almost shut down due to what many believe was manipulation by hedge funds in 2013. It is not even making a profit yet...Saving lives every day for patients with terminal CML and NSCLC.
I am saddened that Bernie Sanders was duped into attacking this poster child of patient care, perseverance and good science. Virtually of ARIAD's income is funneled back into clinical trials and R&D - they have almost no advertising efforts.
I recommend that ALL Ariadfans send their comments to him to his website. Maybe he should visit ARIAD in Cambridge to meet some of the patients that are alive today because of Ponatinib (Hans Loland, for example) and Brigatinib. He could also talk to the world-class doctors
A sad day to see a US Senator duped by the short-traders to attack such a small company when there are actual examples of multi-billion dollar companies that price gouge just to make an incremental profit to their already fat coffers. ARIAD is not one of them!